Overview

Phase III Trial in Acute Promyelocytic Leukemia Patients

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Open label, randomised, phase III multicenter trial.
Phase:
Phase 3
Details
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Collaborator:
Study Alliance Leukemia (SAL) Group
Treatments:
6-Mercaptopurine
Arsenic Trioxide
Idarubicin
Mercaptopurine
Methotrexate
Tretinoin